Skinhealth Systems Inc. income statement
In fiscal 2025, Skinhealth Systems Inc. reported revenue of $301m, down 10.0% on the year before, operating income of −$20.8m (a -6.9% margin) and net income of −$9.5m, or −$0.16 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 167 | 119 | 260 | 366 | 398 | 334 | 301 | 290 |
| Cost of revenue | 60 | 52 | 82 | 117 | 243 | 152 | 104 | 98 |
| Gross profit | 107 | 67 | 179 | 249 | 155 | 182 | 196 | 192 |
| Research and development | 5 | 3 | 8 | 8 | 10 | 6 | 6 | 6 |
| Selling and marketing | 62 | 50 | 112 | 160 | 144 | 118 | 94 | 89 |
| General and administrative | 27 | 31 | 99 | 106 | 131 | 125 | 118 | 102 |
| Operating income | 13 | −17 | −40 | −26 | −131 | −68 | −21 | −4 |
| Interest expense | — | — | 12 | 13 | 14 | 10 | 19 | 25 |
| Income before tax | −3 | −38 | −381 | 45 | −102 | −30 | −6 | −24 |
| Income tax | −1 | −9 | −2 | 1 | −2 | −0 | 4 | 5 |
| Net income | −2 | −29 | −379 | 44 | −100 | −29 | −10 | −28 |
| Diluted EPS | −$0.02 | −$0.28 | −$3.71 | −$0.23 | −$0.76 | −$0.36 | −$0.16 | −$0.21 |
| Diluted shares (average) | 96m | 103m | 102m | 149m | 132m | 142m | 136m | 135m |
| EBITDA | 15 | −15 | −35 | −19 | −120 | −58 | −17 | −2 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 79 | 83 | 70 | 78 | 71 | 82 | 65 | 72 |
| Cost of revenue | 38 | 31 | 21 | 29 | 25 | 29 | 20 | 23 |
| Gross profit | 41 | 52 | 49 | 49 | 46 | 53 | 44 | 49 |
| Research and development | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 |
| Selling and marketing | 28 | 27 | 26 | 23 | 21 | 24 | 23 | 21 |
| General and administrative | 33 | 32 | 34 | 27 | 29 | 28 | 22 | 23 |
| Operating income | −22 | −7 | −12 | −3 | −6 | 0 | −2 | 4 |
| Interest expense | 2 | 2 | 2 | 4 | 6 | 6 | 6 | 6 |
| Income before tax | −16 | −12 | −9 | 19 | −11 | −5 | −7 | −1 |
| Income tax | 2 | −1 | 1 | −1 | 0 | 3 | −0 | 1 |
| Net income | −18 | −10 | −10 | 20 | −11 | −8 | −7 | −3 |
| Diluted EPS | −$0.15 | −$0.05 | −$0.08 | $0.03 | −$0.09 | −$0.05 | −$0.05 | −$0.02 |
| EBITDA | −18 | −6 | −10 | −2 | −6 | 1 | −1 | 4 |
Compare with peers
- Axogen, Inc. income statement
- Orthopediatrics Corp income statement
- Lemaitre Vascular Inc income statement
- Angiodynamics Inc income statement
- Cerus Corp income statement
Head to head: AXGN vs SKINKIDS vs SKINLMAT vs SKIN
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies